About Rockland Immunochemicals
Rockland Immunochemicals is a Healthcare company based in Philadelphia (United States) founded in 1962. Rockland Immunochemicals is engaged in providing antibodies and biotechnology services. It operates on a Professional Services and Direct-to-Consumer (D2C) model. Rockland Immunochemicals has completed 1 acquisition, including antibodies-online. Its website rockland.com draws about 52 thousand monthly visits. Rockland Immunochemicals offers products and services including Primary Antibodies, Custom Antibody Production, and Protein & Antibody Characterization. Its focus areas include Biotechnology and Antibodies & Reagents. Its legal entity is Rockland Immunochemicals, Inc. Its competitors include Catalent, Surrozen and Curia; 1 of its 3 listed competitors has raised funding.
Company details
Rockland Immunochemicals is involved in the development and supply of high-quality antibodies, reagents, and custom services for research and diagnostics. The company serves industries such as AgBio, Biopharma, Diagnostics, and Emerging Therapeutics. Solutions include primary and secondary antibodies, custom antibody production, protein characterization, and assay development. Expertise is applied to advance life sciences through innovative products and technical support, fostering scientific discovery and development across multiple sectors.
- Latest Funding Round$714.07K (USD), Grant
Sep 2014
- Investors
- Investments & Acquisitions
Products & Services of Rockland Immunochemicals
Rockland Immunochemicals offers a comprehensive portfolio of products and services, including Primary Antibodies, Custom Antibody Production, and Protein & Antibody Characterization.
Antibodies are provided for research and diagnostics purposes.
Custom antibodies are developed for specific research needs.
Characterization services are offered for proteins and antibodies.
Apps and channels of Rockland Immunochemicals
its YouTube channel Rockland Immunochemicals, Inc. has 485 subscribers and 30 videos.
Videos from Rockland Immunochemicals
The most watched videos on Rockland Immunochemicals's YouTube channel, Rockland Immunochemicals, Inc. (485 subscribers). Click a video to play it here.
More on Rockland Immunochemicals, Inc..
Funding Insights of Rockland Immunochemicals
- Total Rounds 2
- Last Round Grant — $714,072
- First Round $315,172
(Aug 2009)
- Investors Count 1
All 2 funding rounds of Rockland Immunochemicals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Rockland Immunochemicals
Rockland Immunochemicals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Rockland Immunochemicals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Rockland Immunochemicals
39 people are tracked at Rockland Immunochemicals (10 in leadership, 29 in team).
| Name | Role | Group |
|---|---|---|
Amanda Silveira | Associate Director, Production Operations | Leadership |
David Chimento | Vice President Research And Development | Leadership |
Gisela Marquez | Director Research Operations | Leadership |
Allison van Camp | Marketing Director | Leadership |
Bs Carl Ascoli Ms | Chief Science Officer | Leadership |
James (Jim) Fendrick | President & CEO | Leadership |
Milot Rukiqi Mba, Cscp | Senior Director - Key Accounts | Leadership |
Luke Lindley | Commercial Director | Leadership |
Robert Hooper | Associate Director & Head Of Analytical Services | Leadership |
Stephen Bell | Director, Client Operations | Leadership |
Marcela Pacheco | Sr. Project Manager | Team |
Amber Sawyer | Scientist II | Team |
Anthony Fendrick | Sales Account Manager | Team |
Lori Buuck | Senior Manager Special Projects | Team |
Kevin Bloh Jr. | Scientist III | Team |
Patrick Marison | Cell Culture Scientist | Team |
Sulaiman S. | Project Manager | Team |
Joe McGinnis | QC Scientist | Team |
Sean W. | Technical Support Specialist | Team |
Melissa Ryan | Quality Assurance Specialist II | Team |
19 more people are available in the full profile.
Complete people profiles for Rockland Immunochemicals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rockland Immunochemicals
Rockland Immunochemicals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include antibodies-online.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Online store for selling antibody kits | antibodies-online.com | Aachen, Germany | 2006 | Feb 2022 | •••• |
Complete acquisition details for Rockland Immunochemicals
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Rockland Immunochemicals
4 dated milestones of Rockland Immunochemicals across 60 years, from founding to its latest funding, stage changes and deals.
- Founded Rockland Immunochemicals is founded.
- Funding First funding round of $315K.
- Funding Latest funding round, Grant, of $714K.
- Acquisition Acquires antibodies-online.
Competitors of Rockland Immunochemicals
Rockland Immunochemicals has 3 listed competitors in our database, 1 of them funded. They include Catalent, Surrozen and Curia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| catalent.com | 2007 | Somerset, United States | 9,390 | CDMO offering drug and biologics development services | ||
| surrozen.com | 2016 | San Francisco, United States | $133M | 80 | Selective Wnt agonists are developed for human tissue regeneration. | |
| curiaglobal.com | 1991 | Albany, United States | 1,918 | Drug research, development, testing, and consulting services are provided. |
Detailed competitors of Rockland Immunochemicals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Rockland Immunochemicals
The website of Rockland Immunochemicals (rockland.com) receives about 51.8K visits a month.
- Monthly visits51.8K
▲ 14.1% vs previous month
Websites whose visitors overlap most with Rockland Immunochemicals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| antibodies-online.com | 100% | 57.4K | #648,443 | View details | |
| jacksonimmuno.com | 93% | #680,486 | View details | ||
| raybiotech.com | 88% | 71.1K | #537,358 | View details | |
| bostonbioproducts.com | 88% | #612,153 | View details | ||
| mblbio.com | 88% | #638,515 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Rockland Immunochemicals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Rockland Immunochemicals (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Rockland Immunochemicals
Complete news archive for Rockland Immunochemicals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rockland Immunochemicals
Rockland Immunochemicals was founded in 1962 and raised its 1st funding round 47 years after it was founded.
Rockland Immunochemicals is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Rockland Immunochemicals is involved in the development and supply of high-quality antibodies, reagents, and custom services for research and diagnostics. The company serves industries such as AgBio, Biopharma, Diagnostics, and Emerging Therapeutics. Solutions include primary and secondary antibodies, custom antibody production, protein characterization, and assay development. Expertise is applied to advance life sciences through innovative products and technical support, fostering scientific discovery and development across multiple sectors.
Rockland Immunochemicals offers Primary Antibodies, Custom Antibody Production, and Protein & Antibody Characterization.
Rockland Immunochemicals has made 1 acquisition, including antibodies-online.
Rockland Immunochemicals has 1 investor. Key investors include HHS.
Rockland Immunochemicals operates through Rockland Immunochemicals, Inc..